Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and welcome to the middle of the week. How is everything going so far? Busy as usual, we imagine. The Pharmalot corporate campus, of course, is no exception, where the to-do list is growing longer and there is never enough time. We trust you can relate. So why not cope as we do and reach for a cup or three of stimulation? Nothing like a little kick in the morning. In any event, time now to get cracking. So here are some tidbits. Have a smashing day and drop us a line if you run across anything intriguing... Glaxo Sales In China Drop 61 Percent Due To Scandal (Reuters) Flu Shots Tied To Lower Risk Of Cardiac Events (MedPage Today) New Forest CEO Says Changes Are Planned (Reuters) New Merck Heart Drug Sticks Around A Long Time (Forbes) J&J And Medivir Drug Works Against Hepatitis C (Bloomberg News) Lilly Earnings Beat Forecasts Thanks, In Part, To Cost Cuts (Reuters) Glaxo Employees Evacuated After Plant Leaks Methane (WDRW) Amarin Cuts Staff After FDA Panel Rejects Fish Oil Pill (Bloomberg News) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs